Titre:
  • Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: Subgroup analysis of the natalizumab observational program
Auteur:Van Pesch, Vincent; Sankari, Souraya El; Sindic, Christian Jean Marie; Bartholomé, Emmanuel; Bissay, Véronique; Bouquiaux, Olivier; Bureau, Michel; Caekebeke, Jo F V J.; Debruyne, Jean-Marc; Declercq, Inge; Decoo, Dany; Denayer, Pierre; De Smet, Eric; Van Wijmeersch, Bart; D'hooghe, Marie Beatrice; Dubois, Bénédicte; Dupuis, Michel; Geens, Karine; Guillaume, Daniel; Van Landegem, William; Lysandropoulos, Andreas; de Noordhout, Alain Maertens; Medaer, Robert; Melin, Annick; Peeters, Katelijne; Willems, Christiana; Ba, Rémy Phan; Retif, Cécile; Seeldrayers, Pierette; Symons, Anoek; Urbain, Etienne; Vanderdonckt, Patrick; Van Ingelghem, Erwin; Vanopdenbosch, Ludo; Vanroose, Erwin; Willekens, Barbara
Informations sur la publication:Acta neurologica belgica, 114, 3, page (167-178)
Statut de publication:Publié, 2014
Sujet CREF:Neurologie
Mots-clés:Multiple sclerosis
Natalizumab
Observational study
Safety
Therapeutic efficacy
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0300-9009
info:doi/10.1007/s13760-014-0308-9
info:scp/84906342866